
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
Listing ID:
36324927098
Licence(s) Held:
Fully authorized Colombian entity for cultivation, processing, and international export of THC/CBD ; funding dedicated to scaling GACP certification and EU-GMP pathway compliance.

Seeking $3.0 Million for ~20% equity stake ($12M Pre-Money Valuation), dedicated to funding facility expansion, capacity scaling, and European market growth
Listing Details:
Colombian medical cannabis platform authorized for cultivation, processing, extraction, quality control, packaging, and international export of both THC and non-THC plants
Operations span 14 hoop houses (~30,000 sq ft) and greenhouses on ~80 acres of leased land in Colombia, at 9,000 ft elevation
Year-round cultivation with up to six harvests annually, producing premium flower at consistent 26–27% THC potency
Secured $4.88 million in confirmed in 2026 revenue across 6.5 tons of premium cannabis flower, with revenue projected to rise to $16.1M by 2030 (38% margin) as annual output scales to19 tonnes
Current government-approved cultivation capacity of 208,000 THC plants/year; total authorization recently increased to 500,000 plants (~5 tonnes)
Planned expansion adds 7,056 m² (75,974 sq ft) of greenhouse space supporting additional productions
Very low production costs, representing an 85–95% cost advantage versus Europe and Canada.
Holds exclusive partnerships with award-winning Emerald Triangle cultivators, serving as the regulated pathway to introduce their elite California genetics into the European medical cannabis market
Product portfolio includes premium THC flower (80%) and processing-focused activities (20%), along with proprietary CBD oils, cosmetics, body care, and white-label products
Established market access partnerships across Germany, Portugal, Poland, the U.K., Thailand, and the U.S., with a 5-year strategy to expand to 15+ European partners
Structured as a growth investment, enabling investors to access premium, cost-efficient European-focused cannabis production
36324927098
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
18925796406
Established Alberta cannabis brand with 18 AGLC-Approved SKUs & 6,000 Sq. Ft. cultivation and processing facility – $350K Asset Sale

An operating cannabis brand in Northern Alberta — 40 minutes from the AGLC warehouse — with 18 AGLC-approved SKUs, and a 6,000 sq ft licensed facility, available as a $350,000 asset sale of brand, inventory, and lease.
6891632282
Turnkey, EU GMP & GACP-Certified Canadian Medical Cannabis Producer & International Export Hub for Sale

Rare opportunity to acquire a profitable, fully licensed, EU-GMP certified Canadian medical cannabis producer with international export access. One of fewer than 12 EU-GMP certifications among 800+ Canadian LPs.
3433737347
Turnkey, GACP & CUMCS-Certified 54,000 sq. ft. Cannabis Infrastructure & International Export Hub in Montreal, QC for Sale!

A rare opportunity to acquire a fully licensed, debt-free cannabis enterprise in QC with $11.5M in 2025 revenue, dual international export certifications, and turnkey access to the Quebec market. The sale includes all Health Canada licences, brand IP, equipment, and leasehold operational infrastructure.
